CDKN2A and cancer: Mechanistically, we postulate that p16 may contribute to IFN-γ-dependent activation of tumor-intrinsic cell death, which is required for stable arrest of cancer cells that escape immune-mediated cytotoxicity and thus, long-term cancer control.